Amanote Research
Register
Sign In
Comment On: Evans JMM, Ogston SA, Emslie-Smith A, Morris AD (2006) Risk of Mortality and Adverse Cardiovascular Outcomes in Type 2 Diabetes: A Comparison of Patients Treated With Sulfonylureas and Metformin. Diabetologia 49:930–936
Diabetologia
- Germany
doi 10.1007/s00125-007-0630-3
Full Text
Open PDF
Abstract
Available in
full text
Categories
Internal Medicine
Endocrinology
Metabolism
Diabetes
Date
March 10, 2007
Authors
D. Raccah
Publisher
Springer Science and Business Media LLC
Related search
Sulfonylureas and Cardiovascular Complications of Type 2 Diabetes Mellitus
Diabetes Mellitus
Internal Medicine
Endocrinology
Metabolism
Diabetes
Effects of Aliskiren on Mortality, Cardiovascular Outcomes and Adverse Events in Patients With Diabetes and Cardiovascular Disease or Risk: A Systematic Review and Meta-Analysis of 13,395 Patients
Diabetes and Vascular Disease Research
Internal Medicine
Cardiology
Endocrinology
Cardiovascular Medicine
Metabolism
Diabetes
Monotherapy With Metformin Versus Sulfonylureas and Risk of Cancer in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis
Journal of Diabetes Research
Endocrinology
Metabolism
Diabetes
Cardiovascular Risk in Patients With Type 2 Diabetes
CMAJ
Medicine
Comparison of Antioxidative Effect of Metformin and Combination of Metformin-Sulfonylurea in Type 2 Diabetes Mellitus Patients
Journal of Young Pharmacists
Toxicology
Pharmaceutics
Pharmacology
Metformin in Patients With Type 2 Diabetes and Kidney Disease
JAMA - Journal of the American Medical Association
Medicine
The Influence of Metformin and Presence of Type 2 Diabetes Mellitus on Mortality and Hospitalization in Patients With Heart Failure
Kardiologia Polska
Cardiovascular Medicine
Cardiology
Impact of Diabetes Duration and Cardiovascular Risk Factors on Mortality in Type 2 Diabetes: The Hoorn Study
European Journal of Clinical Investigation
Medicine
Biochemistry
Clinical Biochemistry
Characteristics and Outcomes of Patients With Type 2 Diabetes Mellitus Treated With Canagliflozin: A Real-World Analysis
BMC Endocrine Disorders
Medicine
Endocrinology
Metabolism
Diabetes